-
Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
-
Quantitative systems pharmacology modelling of Parkinson’s disease to compare anti-α-synuclein therapeutics
-
Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence
-
Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.
-
Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects
-
Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease
-
Rapid blinking as an early clinical marker of Parkinson’s disease
-
Rapid Onset Stiff Person Syndrome
-
Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)
-
Rare Neurodegenerative Phenotypes in Patients Carrying Homozygous GBA1 Mutations
- « Previous Page
- 1
- …
- 97
- 98
- 99
- 100
- 101
- …
- 132
- Next Page »